Italy
Healthcare Giants Navigate New Challenges
Amid global health developments, Italy's Recordati might be sold, with CVC Capital exploring options. The U.S. debates the removal of fluoride from water, while Amgen's new drug disappoints, impacting shares. The UK focuses on mental health to boost